Moleculin Biotech (MBRX) announced the appointment of Adriano Treve as a Strategic Advisor for partnerships. He has held senior executive roles across diverse regions, including overseeing U.S. supply chains and serving in General Management positions in Portugal, Brazil, Turkey, and most recently as Area Head for Turkey, Russia, Iran, Central Asia, the Caucasus, Eastern Europe, and the Indian Subcontinent, where he played a pivotal role in broadening access to innovative treatments in underserved markets.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBRX:
- Moleculin Biotech Enters New Stock Offering Agreement
- Moleculin Biotech’s Clinical and Regulatory Advances Drive Buy Rating Amid Promising Phase 3 MIRACLE Study and FDA Feedback
- Moleculin Biotech Gains Approval for Phase 2B/3 AML Study
- Moleculin Biotech receives approval for pivotal Phase 2B/3 study of Annamycin
- Moleculin Biotech Faces Nasdaq Delisting Warning